Randomised, double-blind, double dummy, parallel, multicentre study to compare the efficacy and safety of once-monthly oral administration of 150mg ibandronate with once weekly oral administration of 70mg alendronate in postmenopausal osteoporosis
Phase of Trial: Phase III
Latest Information Update: 02 Jun 2006
At a glance
- Drugs Alendronic acid; Ibandronic acid
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- 02 Jun 2006 New trial record.